Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters

Open access

Abstract

BACKGROUND: Concerns about potential adverse effects of long-term exposure to lithium as a mood-stabilizing treatment notably include altered renal function. However, the incidence of severe renal dysfunction; rate of decline over time; effects of lithium dose, serum concentration, and duration of treatment; relative effects of lithium exposure vs. aging; and contributions of sex and other factors all remain unclear. METHODS: Accordingly, we acquired data from 12 collaborating international sites and 312 bipolar disorder patients (6142 person-years, 2669 assays) treated with lithium carbonate for 8-48 (mean 18) years and aged 20-89 (mean 56) years. We evaluated changes of estimated glomerular filtration rate (eGFR) as well as serum creatinine, urea-nitrogen, and glucose concentrations, white blood cell count, and body-mass index, and tested associations of eGFR with selected factors, using standard bivariate contrasts and regression modeling. RESULTS: . By multivariate regression, risk factors for declining eGFR ranked: longer lithium treatment, lower lithium dose, higher serum lithium concentration, older age, and medical comorbidity. Later low eGFR was also predicted by lower initial eGFR, and starting lithium at age ≥ 40 years. LIMITATIONS: Control data for age-matched subjects not exposed to lithium were lacking. CONCLUSIONS: Long-term lithium treatment was associated with gradual decline of renal functioning (eGFR) by about 30% more than that was associated with aging alone. Risk of subnormal eGFR was from 18.1% (≥2 low values) to 29.5% (≥1 low value), requiring about 30 years of exposure. Additional risk factors for low eGFR were higher serum lithium level, longer lithium treatment, lower initial eGFR, and medical comorbidity, as well as older age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40345-017-0096-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Proportion (%) of subjects with Stages 1, 2, or 3 and 4 of renal function vs. years of lithium exposure. By linear regression, the prevalence of Stage 1 renal function (normal) declined highly significantly (slope [β]: −1.12 [CI −1.36 to −0.88]; t = 10.6, p < 0.0001); Stage 2 (mild dysfunction) remained stable (β: –0.035 [CI −0.373 to 0.303], t = 0.23, p = 0.82); and Stages 3 + 4 increased highly significantly (β: +1.15 [CI 0.91–1.40], t = 10.7, p < 0.0001)
Fig. 1 Proportion (%) of subjects with Stages 1, 2, or 3 and 4 of renal function vs. years of lithium exposure. By linear regression, the prevalence of Stage 1 renal function (normal) declined highly significantly (slope [β]: −1.12 [CI −1.36 to −0.88]; t = 10.6, p < 0.0001); Stage 2 (mild dysfunction) remained stable (β: –0.035 [CI −0.373 to 0.303], t = 0.23, p = 0.82); and Stages 3 + 4 increased highly significantly (β: +1.15 [CI 0.91–1.40], t = 10.7, p < 0.0001)CC BY · PubMed Central
Fig. 2 Values of eGFR (mL/min) [with 95% CI] among men and women: a vs. age; b vs. years of lithium treatment, pooled from 12 international sites, involving 2669 measurements among 312 bipolar disorder subjects treated with lithium for 8–44 years
Fig. 2 Values of eGFR (mL/min) [with 95% CI] among men and women: a vs. age; b vs. years of lithium treatment, pooled from 12 international sites, involving 2669 measurements among 312 bipolar disorder subjects treated with lithium for 8–44 yearsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 125

Metadata

Authors
Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., Müller-Oerlinghausen, B., Murru, A., Perugi, G., Pinna, M., Quaranta, G., Reginaldi, D., Reif, A., Ritter, P., Rybakowski, J. K., Saiger, D., Sani, G., Selle, V., Stamm, T., Vázquez, G. H., Veeh, J., Vieta, E., & Baldessarini, R. J.
Affiliations
  • Harvard University (US)
  • Dalhousie University (CA)
  • University Hospital Carl Gustav Carus (DE)
  • University of Cagliari (IT)
  • Azienda Ospedaliero-Universitaria Cagliari (IT)
  • Freie Universität Berlin (DE)
  • University of Pisa (IT)
  • University of Padua (IT)
  • University Hospital Frankfurt (DE)
  • Poznan University of Medical Sciences (PL)
  • Charité – Universitätsmedizin Berlin (DE)
  • Sapienza University of Rome (IT)
  • Queen's University (CA)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
Corresponding author
Tondo, Leonardo
Venue
International Journal of Bipolar Disorders
Published
2017-08-01
Volume
5
Issue
1
Pages
27-27
ISSN
2194-7511 (ISSN-L)
OpenAlex
W2610823330
Cited by
125
References
65
Citations by year
2026: 9 · 2025: 15 · 2024: 16 · 2023: 17 · 2022: 15 · 2021: 11 · 2020: 17 · 2019: 11 · 2018: 11 · 2017: 3
FWCI
9.44
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • International Journal of Bipolar Disorders (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, cc-by)
Funders
  • Aretæus Foundation
  • Angelini Pharma
  • American Foundation for Suicide Prevention
  • Bundesministerium für Bildung und Forschung
  • German Excellence Initiative to the Graduate School of Life Sciences
  • Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación
  • Canadian Institutes of Health Research (64410)
  • Spanish Ministry of Economy and Competitiveness (00912)
  • Deutsche Forschungsgemeinschaft, European Commission (FP7)
  • the RTG “gk emotions” (1256/2)
  • Fondo Europeo de Desarrollo Regional, Unión Europea
  • CIBERSAM and the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2014-SGR-398)
  • Bruce J. Anderson Foundation
  • McLean Private Donors Research Fund
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
lithium, bipolar disorder, glomerular filtration rate, renal function, lithium carbonate, serum lithium levels, lithium dose, aging, risk factors, serum creatinine, urea nitrogen, glucose, body mass index, white blood cell count, comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. https://app.cochat.ai/papers/10.1186/s40345-017-0096-2
The paper
Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., Müller-Oerlinghausen, B., Murru, A., Perugi, G., Pinna, M., Quaranta, G., Reginaldi, D., Reif, A., Ritter, P., Rybakowski, J. K., . . . Baldessarini, R. J. (2017). Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. International Journal of Bipolar Disorders. https://doi.org/10.1186/s40345-017-0096-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.